Myricetin improves apoptosis after ischemic stroke via inhibiting MAPK-ERK pathway

L Zhang, T Zhou, Q Ji, L He, Y Lan, L Ding, L Li… - Molecular Biology …, 2023 - Springer
Background Neuronal apoptosis is the main cause for the disabilities and deaths of patients
suffered with stroke. Neuroprotectants are clinically used to reduce neuronal apoptosis in …
被引用次数：5 相关文章

Myricetin improves apoptosis after ischemic stroke via inhibiting MAPK-ERK pathway.

L Zhang, T Zhou, Q Ji, L He, Y Lan… - Molecular Biology …, 2023 - search.ebscohost.com
Background: Neuronal apoptosis is the main cause for the disabilities and deaths of patients
suffered with stroke. Neuroprotectants are clinically used to reduce neuronal apoptosis in …

Myricetin improves apoptosis after ischemic stroke via inhibiting MAPK-ERK pathway.

L Zhang, T Zhou, Q Ji, L He, Y Lan, L Ding, L Li… - 2023 - cabidigitallibrary.org
Background: Neuronal apoptosis is the main cause for the disabilities and deaths of patients
suffered with stroke. Neuroprotectants are clinically used to reduce neuronal apoptosis in …

Myricetin improves apoptosis after ischemic stroke via inhibiting MAPK-ERK pathway

L Zhang, T Zhou, Q Ji, L He, Y Lan… - Molecular Biology …, 2023 - search.proquest.com
Background Neuronal apoptosis is the main cause for the disabilities and deaths of patients
suffered with stroke. Neuroprotectants are clinically used to reduce neuronal apoptosis in …

Myricetin improves apoptosis after ischemic stroke via inhibiting MAPK-ERK pathway

L Zhang, T Zhou, Q Ji, L He, Y Lan… - Molecular biology …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Neuronal apoptosis is the main cause for the disabilities and deaths of patients
suffered with stroke. Neuroprotectants are clinically used to reduce neuronal apoptosis in …

Myricetin improves apoptosis after ischemic stroke via inhibiting MAPK-ERK pathway.

L Zhang, T Zhou, Q Ji, L He, Y Lan, L Ding… - Molecular Biology …, 2023 - europepmc.org
Background Neuronal apoptosis is the main cause for the disabilities and deaths of patients
suffered with stroke. Neuroprotectants are clinically used to reduce neuronal apoptosis in …